Following these findings, we assumed that MFA attenuated proliferation and migration ability of HCFs and thus attenuated myocardial fibrosis by suppressing the pRB-E2F1/CCNE2 and the RhoA/ROCK2 pathway (Figure 5F). The gene discussed is E2F1; the disease is Myocardial fibrosis.